Boston Scientific accounts are for healthcare professionals only.
Indications, safety, and warnings
SSPC NXT Delivery Catheter – CTI-IFU-001302 in LAR 97321464
Federal law (USA) restricts this device to sale by or on the order of a licensed practitioner.
Prior to use, please refer to all applicable “Instructions for Use” for more information on Intended Use/Indications for Use, Contraindications, Warnings, Precautions, Potential Adverse Events, and Operator’s Instructions.
INTENDED USE/INDICATIONS FOR USE
The Delivery Catheter is intended for the venous introduction of pacing or defibrillation leads.
CONTRAINDICATIONS
Obstructed or inadequate vasculature for venous access
WARNINGS
Carefully read all instructions prior to use of this product. Observe all warnings and precautions, failure to do so may result in complications
Do not advance Delivery Catheter against resistance without careful assessment of the cause of resistance under fluoroscopy.
Do not advance a lead through the Delivery Catheter against resistance without careful assessment of the cause of resistance under fluoroscopy.
Do not remove the Delivery Catheter or a lead placed through the Delivery Catheter against resistance without careful assessment of the cause of resistance under fluoroscopy.
Do not use if labeling is incomplete or illegible.
Do not use if the package is open or there is any evidence of package or catheter damage.
For single use/single procedure only. Do not reuse, reprocess, or resterilize. Such may cause failure of the tool and/or infection or cross-contamination.
Do not expose the device to the MR environment. Testing has not been performed to establish safe use in this environment.
PRECAUTIONS
Read these instructions and consult the literature provided by the lead manufacturer prior to use.
Care should be taken to consider vessel size and other relevant aspects of patient anatomy relative to the specified size and shape of the selected Delivery Catheter.
Inspect the device and its packaging prior to use. Do not use if damage is detected. Breaks or deformations could interfere with the proper function of the device.
Use the device prior to the by “Use by date” noted on the product label.
Exposure to temperatures above 54°C (130°F) may damage device and accessories.
Do not expose to solvents.
Use in conjunction with fluoroscopic guidance and proper anti-coagulation agents.
Ensure the catheter is thoroughly flushed and free of air prior to use.
Care should be taken during the procedure to ensure that the hemostatic valve is not damaged and that the side port remains closed to reduce potential for air ingress or blood loss.
POTENTIAL ADVERSE EVENTS
Vessel trauma may result from the use of this device. Follow the enclosed directions carefully. Other potential adverse reaction that may result from the use of this device include but are not limited to: Possible complications associated with the Delivery Catheter include delay in procedure, vessel trauma, endocardial trauma, air ingress, blood loss, embolization (material, air), allergic reaction, lead dislodgement, infection, device incompatibility, incomplete therapy.
Possible complications associated with the use of ancillary devices with the Delivery Catheter include:
Air embolism
Bleeding
Bradycardia
Breakage/failure of the implant instrument
Cardiac perforation
Cardiac tamponade
Chronic nerve damage
Death
Extracardiac stimulation (muscle/nerve stimulation)
Hematoma
Heart block
Hemothorax
Incisional pain
Infection including endocarditis
Lead dislodgement
Myocardial infarction
Myocardial trauma
Pericardial effusion
Pericarditis
Pleural Effusion
Pneumothorax
Stroke
Tachyarrhythmias
Thrombosis/thromboemboli
Valve damage
Venous occlusion
Venous trauma (e.g., perforation, dissection, erosion)
Any serious incident that occurs in relation to this device should be reported to CenterPoint Systems LLC and the relevant local regulatory authority.
97339759 A.1